Petar Ilievski

Power3 Medical Products, Inc. (OTC:PWRM) Continues to be a Stock to Watch

by Petar Ilievski April 4, 2011

On the other hand, the decrease in value for the stock is not necessarily a bad thing, especially for traders who are looking to get in. Yet, what they are also looking at is the products of the company and its development since inception until today. Unfortunately, they should wait a bit more since Power3 has just filed a notification that the financial report with an end date Dec. 31st, 2010 would be a little late. Much like for the end of 2009, the company needs more time again.

So, instead of focusing on the finance condition, interested parties should focus on company's products. The key two words here are "patent" and "pending", but there is not really much news about the recent developments in the company, except for the coming from the above mentioned army of promoters. In terms, such environment provides a broad field for speculations. As a yahoo member puts it: "If Nuropro(Power3 product) works, the company would be bought for $25. If not, then bankruptcy is in the future."

Type the characters that you see in the box (5 characters).